Results for: drug+evaluation

Ziopharm rises on preclinical cancer therapy study

US lifts restrictions on anti-diabetes drug Avandia

US seeks tighter controls on certain painkillers

Ziopharm takes bigger loss as research costs grow

US approves handheld injector for painkiller overdose

US, Mexico, Guatemala form anti-crime alliance

Alkermes rises on depression drug study results

BioMarin will continue Pompe disease drug studies

Repros trades higher on new patents for Androxal

News Summary: Court backs FDA in Cytori case

Researchers have made dramatic tuberculosis treatment breakthrough

Stockpiles of Roche Tamiflu drug are waste of money, review finds

Acorda Therapeutics rises on Ampyra study

Affymax cuts jobs, mulls options after recall

Istanbul bid committee says Turkey tough on doping

New kind of trial aims to speed cancer drug development

Sunesis Pharma posts smaller 4th-quarter loss

Teen 'doctor' makes medic claims online, court told

States revolt against powerful new painkiller

Teaching sheep to take their own medicine

FDA clears brain scan to diagnose ADHD in children

US serial killer set to die after court reverse

Pfizer halts study of non-Hodgkin's lymphoma drug

Xoma posts 4Q profit on $16.6M stock gain

Trial leads to permanent youth justice court

US issues rules for removing antibiotics from farms

Mexico leader celebrates education reform victory

US cattle deaths linked to Zilmax far exceed company reports: study

Execution offers evidence against lethal injection

Board lacks authority to track prescription drugs

Report details flaws in Army's handling of PTSD

Royalty Pharma raises bid for Elan to up to $7.2B

Ex-Va. governor seeks FDA, SEC files on witness

Pfizer breast cancer drug gets breakthrough label

CEO of drug maker Teva out ahead job cuts